copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Long-Acting Injectable Antipsychotics (LAIs) - PsychDB Long-Acting Injectable (LAI) Antipsychotics are antipsychotics delivered via intramuscular injection that can provide medication coverage from a period of weeks to months Once stabilized on an LAI, patients rarely will need oral antipsychotic supplementation
A Practical Review of Long-Acting Injectable Antipsychotics ABSTRACT: Long-acting injectable (LAI) antipsychotics are an important treatment option to help improve adherence in patients with schizophrenia and schizoaffective disorder LAI antipsychotics are managed and dosed differently than oral antipsychotics
Improving Outcomes in Schizophrenia With Long-Acting Injectables . . . CONFERENCE REPORTER Patricia Junquera, MD, Maria Collado, MD, and Erin Crown, MHS, PA-C, discussed best practices for use of long-acting injectables (LAIs) at the Southern Florida Psychiatry Conference in West Palm Beach, Florida 1 The presentation covered benefits of LAIs in treatment of schizophrenia, focusing on how they can improve patient outcomes and reduce risk of relapse LAI
LAI Resources: Pocket Guide, Videos, Administrative Toolkit The pocket guide is a resource that pharmacists and other members of the health care team can easily access in practice to quickly locate key information on each of the available psychotropic LAIs
Let’s talk long-acting injectables for schizophren Also known as an “LAI,” it’s an antipsychotic medication that helps treat psychosis (hallucinations or delusions) in those living with schizophrenia • LAIs are given just beneath the skin or into a muscle • LAIs are given every 2 weeks, month, 2 months, 3 months, or 6 months by a doctor or a nurse
A Comprehensive Guide to Long-Acting Injectable Antipsychotics for . . . We propose a paper that provides education on commonly used long-acting injectable antipsychotics (LAIs) to improve primary care based mental health interventions in patients with severe mental illnesses (SMIs) such as schizophrenia, schizoaffective disorder, and bipolar disorders